• SENSEX 77,301.40
    383.55 (+0.50%)
  • BANKNIFTY 55,913.60
    373.55 (+0.67%)
  • NSE
    1,824.90 1,878.00(%)
  • Reliance Industries
    1,318.95 1,611.20(%)
  • Bharti Airtel
    2,068.00 2,174.70(%)
  • SBI Life Insuran
    1,706.80 2,132.90(%)
  • Saregama India
    652.00 652.00(%)
  • Aster DM Quality
    728.05 890.95(%)
  • Multi Comm. Exc.
    3,252.50 1,761.43(%)
  • Jio Platforms
    1,415.00 1,356.40(%)
  • Shree Cement
    24,342.85 28,306.45(%)
  • SFC Enviro.
    397.60 354.05(%)
  • HDFC Bank
    741.00 1,017.90(%)
  • BLS Polymers
    245.95 225.00(%)
  • Global Health
    1,422.10 1,542.00(%)
  • J K Cements
    5,048.20 4,670.05(%)
  • Info Edg.(India)
    1,159.40 909.20(%)
  • ITC
    283.50 414.65(%)
  • SBI
    987.75 1,234.80(%)
  • M & M
    2,952.00 3,840.00(%)
  • Fractal Analyt.
    844.40 1,119.60(%)
  • Ajmera Realty
    145.45 216.02(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Vineet Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 71715.0
  • ISIN : INE505Y01010
37.55 1 (4.13%)
  • As on 05 Nov 2026 (EOD)

  • Today’s Low

    36.01

  • Today’s High

    39.09

  • Open

    36.70

  • Perv Close

    36.06

  • 52W Low

    27.96

  • 52W High

    43.50

Key Indicators

  • P/E(TTM)

    20.88

  • Mar.Cap (₹Cr.)

    72.12

  • Div & Yield %

    0.00

  • Book Value(₹)

    23.75

  • Debt-Equity Ratio

    4.13

  • AGM Date

    04-Nov-2026

  • EPS

    1.82

  • P/E Ratio

    20.88

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    72.12

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    19.21

  • BV (₹)

    23.70

  • Sales( ₹ in Cr.)

    59.40

  • NP (in Cr.)

    1.11

  • NP Var(%)

    105.0

  • Div%

    0.0

  • CPS (₹)

    1.80

  • EPS (₹)

    0.60

  • Traded Value (₹ in Lakhs)

    73.00

  • 52 Week High

    43.50

  • 52 Week Low

    27.96

  • Price BSE

    38.0

  • Price NSE

    38.00

  • Market Capital( in Cr.)

    73.00

  • P/C Ratio

    20.70

  • P/E Ratio

    65.70

  • Price Vs.BV

    0.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 75.00 150.59 212.29 191.17 243.48 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 75.00 150.59 212.29 191.17 243.48 0.00
Other Income 1.99 0.46 0.12 0.29 0.39 0.00
Stock Adjustments -6.47 17.79 -4.23 5.85 -5.36 0.00
Total Income 70.52 168.84 208.18 197.31 238.51 0.00
EXPENDITURE :            
Raw Materials 63.77 131.70 168.10 151.40 192.76 0.00
Power and Fuel Cost 3.99 6.30 6.15 4.74 7.03 0.00
Employee Cost 5.34 6.38 6.00 4.91 5.57 0.00
Other Manufacturing Expenses 8.23 11.63 13.40 16.94 21.20 0.00
Selling and Administration Expenses 3.41 5.10 5.58 5.09 2.42 0.01
Miscellaneous Expenses 0.07 0.07 1.18 0.79 1.00 0.00
Employee Benefit Expenses 5.34 6.38 6.00 4.91 5.57 0.00
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 84.81 161.17 200.41 183.86 229.98 0.01
Operating Profit -14.29 7.66 7.78 13.45 8.54 -0.01
Interest 3.98 4.78 3.38 2.09 2.67 0.00
Gross Profit -18.27 2.88 4.40 11.36 5.87 -0.01
Depreciation 2.50 2.52 2.37 2.02 1.81 0.00
Profit Before Tax -20.77 0.36 2.03 9.34 4.06 -0.01
Current Tax 0.00 -0.06 0.56 3.18 1.28 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.58 -0.60 0.22 -0.48 1.00 0.00
Reported Net Profit -20.19 1.03 1.25 6.64 1.78 -0.01
Extraordinary Items 1.90 0.24 0.00 0.00 0.00 0.00
Adjusted Net Profit -22.09 0.79 1.25 6.64 1.78 -0.01
Adjustment below Net Profit 0.00 0.00 0.00 -0.04 0.22 0.00
P & L Balance brought forward 14.27 13.24 12.91 6.31 4.31 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.92 0.00 0.00 0.00
P & L Balance carried down -5.92 14.27 13.24 12.91 6.31 -0.01
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 10.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 1.00 0.00 0.00
Earnings Per Share-Unit Curr -21.90 1.11 1.36 7.20 1.93 -0.27
Earnings Per Share(Adj)-Unit Curr -18.40 0.93 1.14 6.05 - -
Book Value 15.89 37.67 36.54 36.03 28.87 9.73
Book Value(Adj)-Unit Curr 13.35 31.66 30.70 30.28 - -

Shareholding Pattern

  • Promoter Group

    5.98%

  • Public Share Holding

    94.02%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,149,067 5.98 1,149,067 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,149,067 5.98 1,149,067 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 46,421 0.24 46,421 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 46,421 0.24 46,421 1
2] Non Institution
Bodies Corporate 1,949,204 10.15 1,949,204 35
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 219,090 1.14 219,090 86
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 266,677 1.39 266,677 178
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 10,563,636 55.00 10,563,636 114
Individuals holding nominal share capital up to Rs. 1 lakh 4,918,357 25.61 4,918,357 9,294
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 18,010,778 93.78 18,010,778 9,709
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 19,206,266 100.00 19,206,266 9,724

Company Background

Vineet Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Vineet Laboratories Ltd
  • BSE Code : 71715.0
  • ISIN : INE505Y01010

  • Incorporation Year

    2016

  • Registered Office

    SyNo 11/A3 Saheb Nagar KurduVi
    Chintal Kunta Eshwaramma LB Nr, Hyderabad,
    Telangana-500074

  • Telephone

    91-40-24128833

  • FAX

  • Chairman

    Dilip V Acharekar

  • Managing Director

    Gaddam Venkata Ramana

  • Company Secretary

    Ramesh Kumar Bandari

  • Auditor

    NSVR & Associates LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Vineet Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Vineet Laborator 38.01 76.98 75.00 20.88 0.00
Abbott India 27,146.85 7,217.19 6,929.05 35.73 43.78
Astrazeneca Phar 6,365.10 2,304.07 2,275.58 93.81 27.86
Glaxosmi. Pharma 2,532.60 3,932.76 3,790.20 40.46 58.17
Evonile Pharma 1,736.60 393.10 354.33 43.85 15.94
Cipla 1,400.10 20,102.60 18,979.95 42.67 13.88
Bliss GVS Pharma 625.60 773.53 729.81 40.78 12.51
Amrutanjan Healt 511.45 520.13 502.55 27.39 24.16
Fermenta Biotec. 439.00 474.15 450.25 20.49 18.77
Guj. Themis Bio. 387.70 168.25 165.82 103.66 18.05
Ambalal Sarabhai 35.67 19.52 3.94 66.06 6.77